3716 logo

Cenra Inc. Stock Price

TWSE:3716 Community·NT$5.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

3716 Share Price Performance

NT$0
-38.00 (-100.00%)
NT$0
-38.00 (-100.00%)
Price NT$0

3716 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and good value.

1 Risk
2 Rewards

Cenra Inc. Key Details

NT$8.5b

Revenue

NT$5.2b

Cost of Revenue

NT$3.3b

Gross Profit

NT$2.9b

Other Expenses

NT$378.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
2.59
38.91%
4.42%
34.5%
View Full Analysis

About 3716

Founded
1952
Employees
n/a
CEO
Hou-Kai Wang
WebsiteView website
www.cenra.com

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It provides CDMO services for internal and external partners; oral solids, injectables, specialty formulations, and APIs, supported by process development, scale-up, and regulatory support; oral solids, injectables, specialty formulations, and high-purity active pharmaceutical ingredients (APIs), supported by process development, scale-up, and regulatory support; distribution, and marketing for prescription drugs, OTC products, health supplements, personal care products, and medical devices;home care, caregiver training, and consulting for elderly support; develops and manufactures veterinary pharmaceuticals, and animal health products for livestock and companion animals and offers CDMO services for animal health partners. Cenra Inc. was founded in 1952 and is headquartered in Taipei, Taiwan.

Recent 3716 News & Updates

Recent updates

No updates